Study demonstrates molecular biomarkers improve prostate cancer risk stratification, suggesting better screening strategies.
and Clinical Implications: Our study demonstrates the potential of genetic scores to advance screening guidance. The PC risk stratification capabilities of molecular biomarkers in tiered screening strategies merit further study in large cohorts.
No takes yet. Share an insight, caveat, or question.
Zeltser et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: